Javascript must be enabled to continue!
Percutaneous mitral balloon valvuloplasty. Single versus Inoue balloon. long term follow-up
View through CrossRef
Abstract
Introduction
The single balloon (SB) is the less expensive technique to perform mitral balloon valvuloplasty (MBV). Objectives: This study aimed to demonstrate that MBV with the Balt single (BSB) and Inoue ballon, the wordwire accepted technique, had similar outcome and long-term follow-up (FU).
Methods
From 1987 to 2013, 526 procedures were performed, being 312 with a FU, 56 (17,9%) with Inoue balloon (IB) and 256 (82,1%) with BSB. The mean FU 156±144 months, p<0.0001. Univariate analysis (UA) and multivariate Cox analysis (MCA) to determine independent predict variables of survival and event free survival (EFS) of death, cardiac surgery and new MBV, in both techniques groups.
Results
In IB and BSB groups there were, respectively: female 42 (75.0%) and 222 (86.7%); mean age 37.3±10.0 (19 to 63) and 38.0±12.6 (13 to 83) years, p=0.7138; sinus rhythm 51 (91.1%) and 215 (84.0%), p=0.1754; echo score (ES) 7.6±1.3 (5 to 10) and 7.2±1.5 (4 to 14) points, p=0.0528; echo mitral valve area (MVA) pre-MBV 0.96±0.18 and 0.93±0.21 cm2, p=0.2265; post-MBV mean MVA (Gorlin) were 2.00±0.52 and 2.02±0.37 cm2, p=0.9554; MBV dilatation área 6,09±0,27 and 7,02±0,30, p<0,0001. At the end of the FU, there were in IB and BSB groups, respectively: echo MVA 1.71±0.41 and 1.54±0.51 cm2, p=0.0552; new severe mitral regurgitation in 5 (8.9%) and 17 (6.6%) patients, p=0.5633; new MBV in 1 (1.8%) and 13 (5.1%), p=0.4779; mitral valve surgery in 3 (5.4%) and 27 (10.4%), p=0.3456; deaths 2 (3.6%) and 11 (4.3%), p=1.000; cardiac deaths 1 (1.8%) and 9 (3.5%), p=1.000; ME 5 (8.9%) and 46 (18.0%), p=0.1449. In UA and MCA the BSB or IB technique do not predict survival or EFS. The independent risk factors to survival were: age <50 years (p=0.016, HR=0.233, 95% IC 0.071- 0.764), ES ≤8 (p<0.001, HR=0.105, 95% IC 0.34–0.327), MBV dilatation area (p<0.001, HR 16.838, 95% IC 3.353–84.580) and no mitral valve surgery in the FU (p=0.001, HR0.152, 95% IC 0.050–0.459). Independent risk factors to EFS: no prior commissurotomy (p=0.012, HR=0.390, 95% IC 0.187–0.813) and post-MBV MVA ≥1.50 cm2 (p=0.001, HR=7.969, 95% IC 3.413–18.608).
Conclusion
In 25 years, survival and EFS were similar in BSB and IB technique. Independent predictors of surviva: age <50 years, ES≤8 points, MBV dilatation area >7 mm2 and no mitral valve surgery in the FU. Independent predictors of EFS: no prior commissurotomy and post-MBV MVA≥1.50 cm2
Funding Acknowledgement
Type of funding source: None
Oxford University Press (OUP)
Title: Percutaneous mitral balloon valvuloplasty. Single versus Inoue balloon. long term follow-up
Description:
Abstract
Introduction
The single balloon (SB) is the less expensive technique to perform mitral balloon valvuloplasty (MBV).
Objectives: This study aimed to demonstrate that MBV with the Balt single (BSB) and Inoue ballon, the wordwire accepted technique, had similar outcome and long-term follow-up (FU).
Methods
From 1987 to 2013, 526 procedures were performed, being 312 with a FU, 56 (17,9%) with Inoue balloon (IB) and 256 (82,1%) with BSB.
The mean FU 156±144 months, p<0.
0001.
Univariate analysis (UA) and multivariate Cox analysis (MCA) to determine independent predict variables of survival and event free survival (EFS) of death, cardiac surgery and new MBV, in both techniques groups.
Results
In IB and BSB groups there were, respectively: female 42 (75.
0%) and 222 (86.
7%); mean age 37.
3±10.
0 (19 to 63) and 38.
0±12.
6 (13 to 83) years, p=0.
7138; sinus rhythm 51 (91.
1%) and 215 (84.
0%), p=0.
1754; echo score (ES) 7.
6±1.
3 (5 to 10) and 7.
2±1.
5 (4 to 14) points, p=0.
0528; echo mitral valve area (MVA) pre-MBV 0.
96±0.
18 and 0.
93±0.
21 cm2, p=0.
2265; post-MBV mean MVA (Gorlin) were 2.
00±0.
52 and 2.
02±0.
37 cm2, p=0.
9554; MBV dilatation área 6,09±0,27 and 7,02±0,30, p<0,0001.
At the end of the FU, there were in IB and BSB groups, respectively: echo MVA 1.
71±0.
41 and 1.
54±0.
51 cm2, p=0.
0552; new severe mitral regurgitation in 5 (8.
9%) and 17 (6.
6%) patients, p=0.
5633; new MBV in 1 (1.
8%) and 13 (5.
1%), p=0.
4779; mitral valve surgery in 3 (5.
4%) and 27 (10.
4%), p=0.
3456; deaths 2 (3.
6%) and 11 (4.
3%), p=1.
000; cardiac deaths 1 (1.
8%) and 9 (3.
5%), p=1.
000; ME 5 (8.
9%) and 46 (18.
0%), p=0.
1449.
In UA and MCA the BSB or IB technique do not predict survival or EFS.
The independent risk factors to survival were: age <50 years (p=0.
016, HR=0.
233, 95% IC 0.
071- 0.
764), ES ≤8 (p<0.
001, HR=0.
105, 95% IC 0.
34–0.
327), MBV dilatation area (p<0.
001, HR 16.
838, 95% IC 3.
353–84.
580) and no mitral valve surgery in the FU (p=0.
001, HR0.
152, 95% IC 0.
050–0.
459).
Independent risk factors to EFS: no prior commissurotomy (p=0.
012, HR=0.
390, 95% IC 0.
187–0.
813) and post-MBV MVA ≥1.
50 cm2 (p=0.
001, HR=7.
969, 95% IC 3.
413–18.
608).
Conclusion
In 25 years, survival and EFS were similar in BSB and IB technique.
Independent predictors of surviva: age <50 years, ES≤8 points, MBV dilatation area >7 mm2 and no mitral valve surgery in the FU.
Independent predictors of EFS: no prior commissurotomy and post-MBV MVA≥1.
50 cm2
Funding Acknowledgement
Type of funding source: None.
Related Results
Prior surgical mitral commissurotomy and echocardiographic score influence in mitral balloon valvuloplasty. Immediate post procedure results
Prior surgical mitral commissurotomy and echocardiographic score influence in mitral balloon valvuloplasty. Immediate post procedure results
Abstract
Introduction
Percutaneous mitral balloon valvuloplasty is effective in mitral stenosis. Objectives: to evaluate prior m...
Mitral leaflet separation index correlation with mitral stenosis severity, a reliable easy 2-d echocardiography technique
Mitral leaflet separation index correlation with mitral stenosis severity, a reliable easy 2-d echocardiography technique
Objective: To evaluate accuracy of mitral leaflet separation index for the determination of mitral stenosis severity in patients with rheumatic mitral stenosis.
Method: The prospec...
ANALYSIS OF 293 CASES AFTER PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY
ANALYSIS OF 293 CASES AFTER PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY
Objectives
To observe the short-term results and appropriateness of the use of percutaneous balloon mitral valvuloplasty (PBMV) on the patients with rheumatic mit...
Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review
Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review
Percutaneous mitral valve repair is emerging as a reasonable alternative especially in those with an unfavorable surgical risk profile in the repair of mitral regurgitation. At thi...
89 Simultaneous ocurrence of hammock mitral valve and no-compaction cardiomyopathy
89 Simultaneous ocurrence of hammock mitral valve and no-compaction cardiomyopathy
Abstract
We report a 62-year-old man with a past medical history of dyslipidemia, paranoid schizophrenia and permanent atrial f...
Valvuloplasty Balloon Catheter Sizing Approach for Calcified Aortic Valve with Different Annulus Ratios
Valvuloplasty Balloon Catheter Sizing Approach for Calcified Aortic Valve with Different Annulus Ratios
Transcatheter aortic valve implantation (TAVI) is re- garded as the option of preference minimally invasive intervention to treat high-risk patients with aortic steno- sis, whic...
Ischemic mitral regurgitation: mitral valve replacement, restrictive annuloplasty or multi-component reconstruction with subvalvular intervention (systematic review and meta-analysis)
Ischemic mitral regurgitation: mitral valve replacement, restrictive annuloplasty or multi-component reconstruction with subvalvular intervention (systematic review and meta-analysis)
Objective: The study is aimed at assessing short- and long-term results of various strategies of surgical treatment in patients with ischemic mitral insufficiency.
Methods: The stu...
Research of the treatment in patients with rheumatic mitral stenosis merging left atrial thrombosis by percutaneous balloon mitral valvuloplasty
Research of the treatment in patients with rheumatic mitral stenosis merging left atrial thrombosis by percutaneous balloon mitral valvuloplasty
Objective
To evaluate the feasibility, safety and efficacy of percutaneous balloon mitral valvuloplasy (PBMV) in patients with rheumatic mitral stenosis merging l...


